{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:37:10Z","timestamp":1790397430632,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.medmal.2016.12.001","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T15:16:42Z","timestamp":1483543002000},"page":"253-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The comeback of trimethoprim in France"],"prefix":"10.1016","volume":"47","author":[{"given":"F.","family":"Caron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Wehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2016.12.001_bib0255","first-page":"1076","article-title":"Trimethoprim, co-trimoxazole (Co-T) and related agents","volume":"1","author":"Turnidge","year":"1975"},{"key":"10.1016\/j.medmal.2016.12.001_bib0260","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/clinids\/4.2.402","article-title":"Use of trimethoprim alone or in combination with drugs other than sulfonamides","volume":"4","author":"Brumfitt","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0265","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/clinids\/4.2.358","article-title":"Trimethoprim alone in the treatment of urinary tract infections: eight years of experience in Finland","volume":"4","author":"Kasanen","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"Suppl. 22","key":"10.1016\/j.medmal.2016.12.001_bib0270","first-page":"1","article-title":"Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections","volume":"10","author":"Kasanen","year":"1978","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.medmal.2016.12.001_bib0275","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM197704072961403","article-title":"Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora","volume":"296","author":"Stamey","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2016.12.001_bib0280","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00365540410019075","article-title":"Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002","volume":"36","author":"Andr\u00e9","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0285","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkp387","article-title":"Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use","volume":"65","author":"Sundqvist","year":"2010","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0290","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/AAC.31.10.1451","article-title":"Trimethoprim resistance","volume":"31","author":"Huovinen","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0295","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0140-6736(80)91732-8","article-title":"Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance","volume":"1","author":"Lacey","year":"1980","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.medmal.2016.12.001_bib0300","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/infdis\/128.Supplement_3.S686","article-title":"The concentration of trimethoprim in prostatic fluid: nonionic diffusion or active transport?","volume":"128","author":"Stamey","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0305","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/clinids\/4.2.402","article-title":"Use of trimethoprim alone or in combination with drugs other than sulfonamides","volume":"4","author":"Brumfitt","year":"1982","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0310","first-page":"47","article-title":"The penetration of sulfadiazine, sulfamethoxazole and trimethoprim into the prostate gland, epididymis and testis in man","author":"Sepp\u00e4nen","year":"1980","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.medmal.2016.12.001_bib0315","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/AAC.19.5.842","article-title":"Treatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora","volume":"19","author":"Iravani","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0320","doi-asserted-by":"crossref","first-page":"770","DOI":"10.7326\/0003-4819-92-6-770","article-title":"Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial","volume":"92","author":"Stamm","year":"1980","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.medmal.2016.12.001_bib0325","unstructured":"European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption interactive database (ESAC-Net). http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/esac-net-database\/Pages\/database.aspx (accessed on March 24, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0330","unstructured":"World Health Organisation (WHO)- ATC\/DDD Index. http:\/\/www.whocc.no\/atc_ddd_index\/?code=J01EA&showdescription=yes (accessed on March 25, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0335","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/clinids\/4.2.540","article-title":"Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo","volume":"4","author":"Black","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0340","first-page":"51","article-title":"Trimethoprim and amoxycillin in acute otitis media","volume":"229","author":"Backhouse","year":"1985","journal-title":"Practitioner"},{"key":"10.1016\/j.medmal.2016.12.001_bib0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0190-9622(08)81980-9","article-title":"Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study","volume":"31","author":"Huovinen","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2016.12.001_bib0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/02813432.2013.844410","article-title":"Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe","volume":"31","author":"McQuiston Haslund","year":"2013","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.medmal.2016.12.001_bib0355","series-title":"Diagnostic et antibioth\u00e9rapie des infections urinaires bact\u00e9riennes communautaires de l\u2019adulte","first-page":"1","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF)","year":"2014"},{"key":"10.1016\/j.medmal.2016.12.001_bib0360","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinf.2008.12.009","article-title":"Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials","volume":"58","author":"Falagas","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2016.12.001_bib0370","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.medmal.2016.12.001_bib0375","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkg488","article-title":"Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u00b7SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2016.12.001_bib0385","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40121-015-0095-5","article-title":"Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: a european update for 2014 and comparison with 2000 and 2008","volume":"4","author":"Kahlmeter","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.medmal.2016.12.001_bib0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1179\/joc.2007.19.1.33","article-title":"Uropathogen resistance: are laboratory-generated data reliable enough?","volume":"19","author":"Lopardo","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0395","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/02813430410006521","article-title":"Guidelines, evidence, and cultural factors","volume":"22","author":"Christiaens","year":"2004","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.medmal.2016.12.001_bib0400","series-title":"European Association of Urology guidelines on urological infections","author":"Grabe","year":"2014"},{"key":"10.1016\/j.medmal.2016.12.001_bib0405","unstructured":"Onerba (Observatoire nationale de l\u2019\u00e9pid\u00e9miologie de la r\u00e9sistance bact\u00e9rienne aux antibiotiques)\u00a0: rapport d\u2019activit\u00e9 2013\u20132014. http:\/\/www.onerba.org\/spip.php?article137 (accessed on March 24, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-14-137","article-title":"Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series","volume":"14","author":"Etienne","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2016.12.001_bib0415","first-page":"65","article-title":"Epid\u00e9miologie des E.\u00a0coli urinaires\u00a0: absence d\u2019int\u00e9r\u00eat du cotrimoxazole et du sulfam\u00e9thizole comparativement au trim\u00e9thoprime","volume":"45","author":"Caron","year":"2015","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2016.12.001_bib0420","series-title":"Antibiotic and chemotherapy","first-page":"792","article-title":"Urinary tract infection","author":"Norrby","year":"1997"},{"key":"10.1016\/j.medmal.2016.12.001_bib0425","series-title":"Urinary tract infections","first-page":"95","article-title":"Treatment and prevention of urinary tract infections","author":"Johnson","year":"1996"},{"key":"10.1016\/j.medmal.2016.12.001_bib0430","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.19.4.598","article-title":"Comparative efficacy and safety of nalidixic acid versus trimethoprim\/sulfamethoxazole in treatment of acute urinary tract infections in college-age women","volume":"19","author":"Iravani","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00002018-200022030-00006","article-title":"Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management","volume":"22","author":"Perazella","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.medmal.2016.12.001_bib0440","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pds.3691","article-title":"Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design","volume":"23","author":"Sun","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.medmal.2016.12.001_bib0445","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJM198201213060302","article-title":"Emergence of high-level trimethoprim resistance in fecal Escherichia coliduring oral administration of trimethoprim or trimethoprim-sulfamethoxazole","volume":"306","author":"Murray","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2016.12.001_bib0450","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/AAC.28.2.354","article-title":"Emergence of trimethoprim resistance in fecal flora","volume":"28","author":"Huovinen","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0455","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/jac\/dks222","article-title":"Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model","volume":"67","author":"Vellinga","year":"2012","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0460","first-page":"221","article-title":"Guidelines adherence to lower urinary tract infection treatment in out-of-hours primary care in European countries","volume":"22","author":"Philips","year":"2014","journal-title":"Qual Prim Care"},{"key":"10.1016\/j.medmal.2016.12.001_bib0465","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/48.6.895","article-title":"Antibiotic failure in the treatment of urinary tract infections in young women","volume":"48","author":"Lawrenson","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0470","unstructured":"Adult Uncomplicated UTI i.e. no fever or flank pain - Antimicrobial Prescribing Guidelines. Antibioticprescribing Ie n.d. http:\/\/www.antibioticprescribing.ie\/urinary\/adult-uncomplicated-uti (accessed on March 25, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0475","unstructured":"Health Service Executive H, Irish College of General Practitionners I, Royal College of Physicians of Ireland R, Health Protection Surveillance Center. Guidelines for antimicrobial prescribing in primary care in Ireland. http:\/\/www.antibioticprescribing.ie\/urinary\/adult-uncomplicated-uti (accessed on March 29, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0480","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise S. Place du trimethoprime et de la t\u00e9mocilline. http:\/\/www.infectiologie.com\/UserFiles\/File\/spilf\/recos\/infections-urinaires-spilf-trimethoprime-temocilline-2015.pdf (accessed on March 29, 2016)."},{"key":"10.1016\/j.medmal.2016.12.001_bib0485","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","author":"Rudenko","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.medmal.2016.12.001_bib0490","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2016.12.001_bib0495","first-page":"CD001209","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2016.12.001_bib0500","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.juro.2010.03.084","article-title":"Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. \u2013 PubMed \u2013 NCBI","volume":"184","author":"Nguyen","year":"2010","journal-title":"J Urol"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16308344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X16308344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:14:56Z","timestamp":1759972496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X16308344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0399077X16308344"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2016.12.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734641220.793554305","asserted-by":"object"}]},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The comeback of trimethoprim in France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}